Immunohematological Reference Ranges for Adult Ethiopians
Overview
Affiliations
A cross-sectional survey was carried out with 485 healthy working adult Ethiopians who are participating in a cohort study on the progression of human immunodeficiency virus type 1 (HIV-1) infection to establish hematological reference ranges for adult HIV-negative Ethiopians. In addition, enumeration of absolute numbers and percentages of leukocyte subsets was performed for 142 randomly selected HIV-negative individuals. Immunological results were compared to those of 1,356 healthy HIV-negative Dutch blood donor controls. Immunohematological mean values, medians, and 95th percentile reference ranges were established. Mean values were as follows: leukocyte (WBC) counts, 6.1 x 10(9)/liter (both genders); erythrocyte counts, 5.1 x 10(12)/liter (males) and 4.5 x 10(12)/liter (females); hemoglobin, 16.1 (male) and 14.3 (female) g/dl; hematocrit, 48.3% (male) and 42.0% (female); platelets, 205 x 10(9)/liter (both genders); monocytes, 343/microl; granulocytes, 3, 057/microl; lymphocytes, 1,857/microl; CD4 T cells, 775/microl; CD8 T cells, 747/microl; CD4/CD8 T-cell ratio, 1.2; T cells, 1, 555/microl; B cells, 191/microl; and NK cells, 250/microl. The major conclusions follow. (i) The WBC and platelet values of healthy HIV-negative Ethiopians are lower than the adopted reference values of Ethiopia. (ii) The absolute CD4 T-cell counts of healthy HIV-negative Ethiopians are considerably lower than those of the Dutch controls, while the opposite is true for the absolute CD8 T-cell counts. This results in a significantly reduced CD4/CD8 T-cell ratio for healthy Ethiopians, compared to the ratio for Dutch controls.
Chalchisa D, Belay Y, Befekadu E, Kassaw M, GEgzeabher L, Gebremicael G Int J Gen Med. 2022; 15:5361-5367.
PMID: 35677805 PMC: 9167834. DOI: 10.2147/IJGM.S357237.
Hematologic reference intervals for healthy adult Saudis in Riyadh.
Bakr S, AlFattani A, Al-Nounou R, Bakshi N, Khogeer H, Alharbi M Ann Saudi Med. 2022; 42(3):191-203.
PMID: 35658586 PMC: 9167458. DOI: 10.5144/0256-4947.2022.191.
Fiseha T, Ebrahim H, Ebrahim E, Gebreweld A PLoS One. 2022; 17(3):e0265740.
PMID: 35324948 PMC: 8947242. DOI: 10.1371/journal.pone.0265740.
Perazzio S, Palmeira P, Moraes-Vasconcelos D, Rangel-Santos A, de Oliveira J, Andrade L Front Immunol. 2021; 12:721289.
PMID: 34858394 PMC: 8630704. DOI: 10.3389/fimmu.2021.721289.
Wolday D, Ndungu F, Gomez-Perez G, Wit T Front Immunol. 2021; 12:693269.
PMID: 34220854 PMC: 8249933. DOI: 10.3389/fimmu.2021.693269.